LRMR News and Press, Larimar Therapeutics Inc. From 02/14/24

2024-02-14 13:54:31 ET More on Mid-day movers & stocks. Financial information for Brera Holdings PLC Financial information for Datasea Seeking Alpha’s Quant Rating on Tenon Medical Historical earnings data for Tenon Medical Financial inform...

2024-02-14 06:37:40 ET Read the full article on Seeking Alpha For further details see: Larimar Therapeutics rises after pricing $150M stock offering

BALA CYNWYD, Pa., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public o...

2024-02-13 17:30:16 ET Gainers: Lyft ( LYFT ) +18% . Larimar Therapeutics ( LRMR ) +15% . CEVA ( CEVA ) +9% . Robinhood Markets ( HOOD ) +9% . FibroBiologics ( FBLG ) +8% . Losers: QuidelOrtho Corporation ( QDEL ) -...

2024-02-13 16:22:15 ET More on Larimar Therapeutics Larimar aiming to file for accelerated approval in 2H 2025 Seeking Alpha’s Quant Rating on Larimar Therapeutics Historical earnings data for Larimar Therapeutics Financial information for Larimar Ther...

BALA CYNWYD, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an underwritten public offering of shar...

Larimar Therapeutics, Inc. (NASDAQ: LRMR) is one of today's top gainers. The company's shares have moved 25.16% on the day to $9.8. Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide te...

2024-02-13 10:00:06 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Communication Services, Info Tec...

2024-02-12 16:46:59 ET More on Biogen Biotech And Pharma Diversification Pays Off Biogen Inc. (BIIB) JPMorgan 42nd Annual Healthcare Conference (Transcript) Biogen: LEQEMBI's $10 Billion Potential Biogen Q4 2023 Earnings Preview Biogen scraps Aduhelm,...

2024-02-12 10:15:57 ET More on Larimar Therapeutics Seeking Alpha’s Quant Rating on Larimar Therapeutics Historical earnings data for Larimar Therapeutics Financial information for Larimar Therapeutics Read the full article on Seeking Alpha For...